Champions Oncology CSBR Q1 2026 Earnings EPS Misses by Wide Margin as Company Posts Loss NTST Q1 2026 Earnings EPS Miss Amid Challenging Market Conditions KAPA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Clinical Pipeline APEI Q1 2026 Earnings EPS Surges Past Estimates with 383 Beat AIM ImmunoTech Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment ESLA Q1 2026 Earnings EPS Misses Estimates by Wide Margin as ClinicalStage Biotech Continues RD Spending